| Pharmaceutical active ingredients: |
| Phenformin |
| Available forms, composition and doses of D Bretard: |
| N / A |
| D Bretard medical category: |
| Human:Antidiabetic agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A10BA01 - Phenformin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Cytostasan | Bendamustine | Unidentified Pharmaceutical Company |
| Cyuram DS | Tetramethylthiuram | Unidentified Pharmaceutical Company |
| Cyzone | N-Isopropyl-N'-Phenyl-Para-Phenylenediamine | Unidentified Pharmaceutical Company |
| Cyzone IP | N-Isopropyl-N'-Phenyl-Para-Phenylenediamine | Unidentified Pharmaceutical Company |
| Czterochlorek Wegla | Carbon Tetrachloride | Unidentified Pharmaceutical Company |
| D3-Vigantol | Vitamin D3 | Unidentified Pharmaceutical Company |
| Dabiase K-27 | Amylase | Unidentified Pharmaceutical Company |
| Dabrosin | Allopurinol | Unidentified Pharmaceutical Company |
| Dacartil | Normethadone | Unidentified Pharmaceutical Company |
| Dacorsol | Prednylidene | Unidentified Pharmaceutical Company |